Wells Fargo’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-250
| Closed | -$1.02K | – | 6484 |
|
|
2024
Q2 | $1.02K | Sell |
250
-22
| -8% | -$90 | ﹤0.01% | 5707 |
|
|
2024
Q1 | $1.82K | Hold |
272
| – | – | ﹤0.01% | 5658 |
|
|
2023
Q4 | $1.28K | Buy |
272
+2
| +0.7% | +$9 | ﹤0.01% | 5732 |
|
|
2023
Q3 | $1.13K | Sell |
270
-3
| -1% | -$13 | ﹤0.01% | 5802 |
|
|
2023
Q2 | $860 | Buy |
273
+9
| +3% | +$28 | ﹤0.01% | 6043 |
|
|
2023
Q1 | $1.17K | Hold |
264
| – | – | ﹤0.01% | 6012 |
|
|
2022
Q4 | $1.75K | Buy |
264
+257
| +3,671% | +$1.7K | ﹤0.01% | 5715 |
|
|
2022
Q3 | $0 | Sell |
7
-23
| -77% | – | ﹤0.01% | 6288 |
|
|
2022
Q2 | $0 | Buy |
30
+25
| +500% | – | ﹤0.01% | 6459 |
|
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 6630 |
|
|
2021
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 6620 |
|
|
2021
Q2 | – | Sell |
-1,515
| Closed | -$155K | – | 6519 |
|
|
2021
Q1 | $155K | Buy |
1,515
+1,239
| +449% | +$127K | ﹤0.01% | 4957 |
|
|
2020
Q4 | $27K | Sell |
276
-343
| -55% | -$33.6K | ﹤0.01% | 5552 |
|
|
2020
Q3 | $298K | Buy |
619
+38
| +7% | +$18.3K | ﹤0.01% | 4579 |
|
|
2020
Q2 | $451K | Buy |
581
+232
| +66% | +$180K | ﹤0.01% | 4284 |
|
|
2020
Q1 | $242K | Buy |
349
+323
| +1,242% | +$224K | ﹤0.01% | 4404 |
|
|
2019
Q4 | $24K | Buy |
+26
| New | +$24K | ﹤0.01% | 5414 |
|